tiprankstipranks
Advertisement
Advertisement
Buy Rating on iBio Driven by Promising IBIO-610 Obesity Data and Favorable Risk-Reward Profile
PremiumRatingsBuy Rating on iBio Driven by Promising IBIO-610 Obesity Data and Favorable Risk-Reward Profile
27d ago
iBio Highlights IBIO-610 Obesity and Cardiometabolic Potential
Premium
Company Announcements
iBio Highlights IBIO-610 Obesity and Cardiometabolic Potential
27d ago
iBio announces new preclinical data from study evaluating IBIO-610
Premium
The Fly
iBio announces new preclinical data from study evaluating IBIO-610
27d ago
iBio: Differentiated Activin E Obesity Pipeline and Strengthened Balance Sheet Underpin Buy Rating
PremiumRatingsiBio: Differentiated Activin E Obesity Pipeline and Strengthened Balance Sheet Underpin Buy Rating
2M ago
iBio reports Q2 EPS (9c), consensus (6c)
Premium
The Fly
iBio reports Q2 EPS (9c), consensus (6c)
2M ago
iBio files to sell 11.06M shares of common stock for holders
Premium
The Fly
iBio files to sell 11.06M shares of common stock for holders
2M ago
Ibio, RLMD, SEE, OLLI, Invivyd Trending With Analysts
PremiumWeekend UpdatesIbio, RLMD, SEE, OLLI, Invivyd Trending With Analysts
3M ago
iBio initiated with an Outperform at LifeSci Capital
Premium
The Fly
iBio initiated with an Outperform at LifeSci Capital
4M ago
iBio initiated with an Outperform at LifeSci Capital
Premium
The Fly
iBio initiated with an Outperform at LifeSci Capital
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100